Core Scientific, Inc.
CORZ
$19.61
-$0.18-0.89%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -232.76% | -262.12% | 246.02% | 84.34% | -262.57% |
| Total Depreciation and Amortization | 31.54% | 184.63% | -69.49% | -20.64% | 22.45% |
| Total Amortization of Deferred Charges | -200.00% | 27.09% | 0.53% | 175.69% | -200.00% |
| Total Other Non-Cash Items | 108.04% | 300.79% | -756.94% | -95.37% | 228.14% |
| Change in Net Operating Assets | -33.24% | -67.09% | -13.62% | 111.40% | 523.69% |
| Cash from Operations | -107.57% | 63.25% | 16.15% | 287.59% | 175.49% |
| Capital Expenditure | -45.16% | -41.64% | -12.40% | -101.60% | -44.41% |
| Sale of Property, Plant, and Equipment | -50.63% | 71.61% | 493.80% | -84.56% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -422,661.82% | -7.84% | 99.50% | -- | 100.00% |
| Cash from Investing | -105.93% | -41.46% | -7.46% | -112.66% | -34.37% |
| Total Debt Issued | 229.67% | -- | -- | -- | -- |
| Total Debt Repaid | -91,124.20% | -68.46% | -18.83% | 98.24% | -594.69% |
| Issuance of Common Stock | -- | -98.43% | 362.81% | -- | -- |
| Repurchase of Common Stock | 37.07% | 17.48% | -346.68% | -2,115.41% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5,240.48% | -- | -- | -- | -- |
| Cash from Financing | 128.60% | 4,554.25% | -309.62% | 83.24% | -656.84% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 68.39% | 687.48% | -11.07% | -8.96% | 15.10% |